GL1X · GenesisL1 explorer

MolNFT v1 · #10473 · protein

Crystal structure analysis of bst-1/CD157 complexed with nmn

1ISJ · Bone marrow stromal cell antigen 1: “Crystal structure analysis of bst-1/CD157 complexed with nmn”. X-ray diffraction, 2 ligands (NMN, NAG), 5 pockets (best druggability 0.78). MolNFT v1 #10473 on GenesisL1: 3D structure, binding…

PDB
1ISJ
Type
protein
Length
500 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bone marrow stromal cell antigen 1
EC
3.2.2.5
UniProt
Q10588
Ligands
NMN, NAG
Pockets
5 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBone marrow stromal cell antigen 1 (EC 3.2.2.5)protein25040% helix, 12% strandQ10588

Ligands and binding sites

  • NMN · Beta-nicotinamide ribose monophosphate · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19870.780.8176empty
21920.570.8020NMN
32180.570.7934NMN
4840.370.7718empty
5530.280.7515empty

Interfaces

1 interface between chains.

  • A–B · 1405 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 1ISJ · Crystal Structure Analysis of BST-1/CD157 complexed with NMN · the same entry in another collection · chain A against A, TM-score 1.00
  • Q10588 · AlphaFold monomer V2.0 prediction for ADP-ribosyl CYCLASE/CYCLIC ADP- ribose hydrolase 2… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.